|
RPIA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.290400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.290100E-02 |
| Normal-vs-Stage2 |
3.470600E-01 |
| Normal-vs-Stage3 |
9.933400E-01 |
| Normal-vs-Stage4 |
9.790000E-01 |
| Stage1-vs-Stage2 |
9.802100E-03 |
| Stage1-vs-Stage3 |
4.187700E-02 |
| Stage1-vs-Stage4 |
1.179200E-01 |
| Stage2-vs-Stage3 |
3.208000E-01 |
| Stage2-vs-Stage4 |
3.786400E-01 |
| Stage3-vs-Stage4 |
9.713600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.157000E-01 |
| Normal-vs-AfricanAmerican |
6.183800E-01 |
| Normal-vs-Asian |
6.981400E-03 |
| Caucasian-vs-AfricanAmerican |
8.457200E-01 |
| Caucasian-vs-Asian |
3.113900E-02 |
| AfricanAmerican-vs-Asian |
1.070220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.650800E-01 |
| Normal-vs-Female |
1.539640E-01 |
| Male-vs-Female |
3.889900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.978490E-02 |
| Normal-vs-Age(41-60Yrs) |
8.941200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.303600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.059400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.617100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.992900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.450400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.748230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.797200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.327600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.393400E-01 |
| Classical-VS-Follicular |
2.98060000003542E-06 |
| Classical-VS-Other |
1.146990E-01 |
| Classical-VS-Normal |
3.294300E-02 |
| Tall-VS-Follicular |
6.629900E-02 |
| Tall-VS-Other |
3.849400E-01 |
| Tall-VS-Normal |
6.354200E-01 |
| Follicular-VS-Other |
8.477200E-01 |
| Follicular-VS-Normal |
5.181900E-02 |
| Other-VS-Normal |
4.679600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.170600E-01 |
| Normal-vs-N1 |
3.369400E-01 |
| N0-vs-N1 |
2.460000E-01 |
|
|
